Corcept Therapeutics Inc. (CORT), which posted strong financial results for the third quarter yesterday, is anticipating a ...

Sabrina Gomes, 24, has seen her skin get progressively darker since having a surgical procedure two years ago, but has had to fight in court to get the expensive treatment that could reverse it ...

By the time he died, Henry VIII was plagued by illness, frequently depressed, suffered violent mood swings and was ...

In Nebraska, the only state with competing pro-life and pro-abortion ballot measures, Archbishop George Lucas of Omaha urged ...

Corcept's Phase 3 GRADIENT trial for relacorilant has missed its primary endpoint – the improvement in SBP for Cushing's ...

Louisiana health care workers and advocates filed a lawsuit Thursday challenging a recently passed state law reclassifying ...

CORT beats on both earnings and sales in the third quarter of 2024. The company increases the revenue guidance for 2024. Stock falls in after-hours trading.

Pentixapharm itself is currently preparing a US-centric Phase III pivotal study to obtain marketing authorization for PentixaFor in PA. The work of the NCI/NIDDK will add to the global clinical ...

Sparrow Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and immunology, today announced that the Phase 2 ...

Plus: A new class of materials for carbon capture, Blue Origin’s new spaceship and the science-approved way to throw a ...

A hormone associated with stress, cortisol, can significantly influence not only your health but also your appearance.